Head and Neck Cancers Coverage From Every Angle

Thomas Galloway, MD, on Oropharyngeal Cancer: Improving Outcomes, Reducing Toxicity, and Guideline Recommendations

Posted: Monday, November 5, 2018

Thomas Galloway, MD, of Fox Chase Cancer Center, summarizes a session on head and neck cancer that included findings on reducing oral mucositis, improving quality of life with deintensified chemoradiotherapy, and the costs of dose de-escalation, in light of NCCN Guidelines.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.